Quva Pharma, INC.
At a glance
Employees500+
In business sinceNot reported
HeadquartersSugar Land, TX
US patents5
SAM.gov UEIMUABDCZXMLG4
CAGE code7VLA4
Incorporated inDE
LEI254900X6X9T3IIJTL168
- sterile injectable compounding
- pharmacy services
- data insights
- supports
- ordering
- health system
- shortages
- diversion
Named on the company’s own website, read JUL 29, 2026
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Certifications
FDA registered
Patents
5 US patents granted 2021–2025, 5 of them in the five years to SEP 2025, including 1 design patent.
Pharmaceuticals 4
- Ready to use LET formulationsUS 12,409,155 · granted SEP 9, 2025
- Ready to use liquid formulationUS 11,642,308 · granted MAY 9, 2023
- Drug syringe safely labelUS D942544 · granted FEB 1, 2022
- Ready to use liquid RECK formulationUS 10,952,963 · granted MAR 23, 2021
- Ready to use liquid formulationUS 10,952,962 · granted MAR 23, 2021
Granted to QuVa Pharma Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Quva Pharma, INC. | Sugar Land | TX | 500+ | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.